Fundraising Fox
/Companies
Sign in

Cardiodx

Redwood City, US · Delaware corporation · 2 known investors

Find your way into Cardiodx

Each arrow is one introduction. Sign up to fill in the first one.

278 people can intro you to Deborah

Ask Adam Sharkawy to introduce you to Deborah Kilpatrick

You →Adam · together at NextGen Jane →Deborah

Sign up to find every way you can get introduced to Cardiodx

  • Your email: who you already know at Cardiodx, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cardiodx team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Molecular diagnostics company commercializing tools for diagnosing cardiovascular disease.

Biotech

Founders & leadership

MMMark Monane
Mark MonaneExecutive
GRGwen R. Carscadden
Gwen R. CarscaddenExecutive
DL
David L. LevisonExecutive
DLDeborah L. Kilpatrick
Deborah L. KilpatrickVP Market Development, SVP Commercial2006–2012Deborah L. Kilpatrick is an executive at Cardiodx with experience in research, development, and commercialization of healthcare technologies, medical devices, and diagnostics across Fortune 500 companies and startup environments. She has held operational leadership roles in R&D, technology incubation, and commercialization, and co-founded an annual conference for women in medtech business, investment, and clinical roles.
RF
Robert F. WernerExecutive
DT
Douglas T. RossExecutive
MG
Melinda GriffithExecutive

Board

PG
Patrick G. EnrightBoard director
LL
Louis LangeBoard director
AS
Ajit SinghBoard director
HH
Hongjie HuBoard director
BH
Brook H. ByersBoard director

Investors · 2

Pappas Capitallisted by Pappas CapitalDurham

How we know: Pappas Capital's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$51.5M disclosed across 3 rounds · 2014–2017

▶$18.1MraisedJan 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hongjie HuDirector
  • Mark MonaneExecutive Officer
  • Patrick G. EnrightDirector
  • Ajit SinghDirector
  • David L. LevisonDirector
  • Tim HennExecutive Officer
  • Khushro F. MehtaExecutive Officer, Director
  • Susan DanielsExecutive Officer
  • Jim WingroveExecutive Officer
  • Duane WilliamsExecutive Officer
Offering amount
$41.8M
Amount sold
$18.1M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.4MraisedFeb 2016 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark MonaneExecutive Officer
  • Patrick G. EnrightDirector
  • Gwen R. CarscaddenExecutive Officer
  • Louis LangeDirector
  • Andrew L. GuggenhimeDirector
  • James R. TobinDirector
  • David L. LevisonExecutive Officer, Director
  • Ajit SinghDirector
  • Hongjie HuDirector
Offering amount
$25.5M
Amount sold
$12.4M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedJul 2014 · 14 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Patrick G. EnrightDirector
  • David L. LevisonExecutive Officer, Director
  • Mark MonaneExecutive Officer
  • Brook H. ByersDirector
  • Deborah L. KilpatrickExecutive Officer
  • Robert F. WernerExecutive Officer
  • Andrew L. GuggenhimeDirector
  • Douglas T. RossExecutive Officer
  • Melinda GriffithExecutive Officer
  • Ajit SinghDirector
  • Gwen R. CarscaddenExecutive Officer
  • Louis LangeDirector
  • James R. TobinDirector
Offering amount
$25M
Amount sold
$21M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cardiodx do?
Molecular diagnostics company commercializing tools for diagnosing cardiovascular disease.
Who are Cardiodx's investors?
Cardiodx's investors include Longitude Capital, Pappas Capital.
How much funding has Cardiodx raised?
Cardiodx has disclosed $51.5M raised across 3 rounds.
Where is Cardiodx headquartered?
Cardiodx is headquartered in Redwood City, US.